Organigram’s proposed acquisition of Sanity Group  establishes Organigram as a Dominant Global Pure Play Cannabis Company with Leadership Positions in Two of the World’s Largest Federally Legal Cannabis Markets

​

Together, the companies bring complementary strengths—Sanity Group’s Europe-focused business, brands and market expertise, and Organigram’s scale and capabilities—supporting a stronger base for international growth in regulated cannabis markets.